Dernières nouvelles pour Catheter Precision (AMEX:VTAK) Stock

Catheter Precision, Inc. Common Stock

Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System), which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.

Catheter Precision

Catheter Precision Inc

News

Offerings

GDTC

CytoMed Therapeutics Files For Mixed Shelf Of Up To $50M

The legality of hemp is a matter of margins. The Farm Bill legalized hemp-derived cannabinoids in 2018 as long as the plant remained below a threshold of 0.3% Delta-9 THC by dry weight. Cannabis cousin compounds – CBD, THCA, Delta-8 THC, and a slew of minor cannabinoids – were therefore legal provided they met this concentration for Delta-9. The floodgates opened and cannabis products were now available from gas stations to doorstep delivery.
But this rule isn't set in stone. The Farm Bill is meant to be updated every five years and, following two year-long delays, is scheduled for debate and passage this year. This time, senators are fighting back, particularly against psychoactive cannabinoids they view as a loophole in need of closing. 
Early indications suggest lawmakers will push for a total THC standard of 0.3%, potentially curbing access to minor cannabinoids and undoing the scientific, social, and production progress made in this space. Let's take a deeper look at how tenths of a percent will define and ultimately decide the future of legal hemp.
The threshold debate cuts both ways
Last year's postponed draft bill offered the first indication lawmakers wanted to shift from a 0.3% Delta-9 THC standard to a 0.3% total THC standard, encompassing THCA and other THC variants. While this wouldn't likely affect non-THC cannabinoids like CBD, it would target psychoactive cannabinoids.
Ironically, this more restrictive proposal came as other lawmakers argued in the opposite direction. Republican Senator Rand Paul believes the dry weight concentration is too low – and should be tripled – since current rules require testing the flower rather than the final product. This can easily lead to "hot" crops above 0.3%, a real problem with the USDA estimating <a href="https://www.govinfo.gov/content/pkg/FR-2019-10-31/pdf/2019-23749.pdf">about 20% of hemp grown</a> during the crop year exceeds legal THC limits.
Up or down, senators aren't happy with the THC threshold status quo and particularly the newfound legality of psychoactive cannabinoids. This has been a sticking point for conservative lawmakers who feel "duped" that they didn't intend to legalize intoxicating cannabinoids with hemp. As a result, more than 20 states have active bans against cannabinoids like Delta-8, creating a patchwork of production and consumer rules across the country.
A spectrum of cannabinoids
It's worth reiterating that not all cannabinoids are equal. There's an entire world of <a href="https://vitalitycbd.com/what-are-cannabinoids/">more than 120 minor cannabinoids</a> in the hemp plant, with the spectrum ranging from non-psychoactive compounds with solely wellness applications, such as CBD, to psychoactive compounds primarily intended for recreational use, like THCA. And we're only scratching the surface.
The Farm Bill removed red tape and finally let researchers dig into the plant's potential. Early results are promising with CBD proving anecdotal benefits under lab conditions for things like anxiety, inflammation, and sleep. Meanwhile, research into other minor cannabinoids (psychoactive and non-psychoactive) suggests therapeutic applications for conditions such as neuropathic pain, neurodegenerative diseases, skin disorders, and even cancer.
This is important to mention because a total concentration standard could shut the door on some minor cannabinoids and stop this progress in its tracks.&nbsp;
Industry and consumers need clarity
Unfortunately, industry stakeholders will need to wait and see what's next. Congress is getting good at kicking the cannabinoid can down the road, and it seems their legislative agenda is currently focused on the budget. <a href="https://www.agweb.com/news/policy/ag-economy/59-ag-economists-think-congress-wont-pass-new-farm-bill-until-2026">About 60%</a> of agricultural economists believe the Farm Bill – yet again – will go on hold until 2026 due to shifting government priorities.
Regardless of timing, this debate will continue to rage on. And, at the heart of the matter, is how we test products for consumption. I agree that the threshold should be measured against final products rather than raw flower, and producers shouldn't be penalized when concentration factors are often beyond their control. In this regard, there's merit to raising the limit to 1% and only testing the final formulation.
However, it's harder to see the benefit of eliminating psychoactive cannabinoids through a blanket total threshold. From my perspective, as well as that of many in the industry, better production standards and stricter compliance could achieve the same consumer protection goals without further complicating the dry weight framework.
Don't get me wrong – this sector isn't perfect. Some bad actors cut corners on testing and quality, and those of us committed to best practices like organic production, third-party lab verification, and proper labeling welcome rules that raise the bar for consumers. However, a total THC threshold feels like a one-size-fits-all approach that merely seeks to penalize psychoactive cannabinoids. Further, it doesn't address the quality control vacuum left by federal inaction.
Let's hope in the remaining months (or years) of bill debate that industry and lawmakers can come together in good faith to find a solution that works for all sides – one that protects consumers while preserving the promising research and business development we've seen since 2018. Those tenths of a percent may seem insignificant but the stakes couldn't be higher.

Cannabis

Regulations

Opinion

General

Tenths Of A Percent Will Decide The Future Of Legal Hemp

Management

Rapid7 Appoints Marc Brown As Chairman Of The Board; Corey Thomas To Continue As CEO And Board Member

On June 12, 2025, FibroGen ("FibroGen" or the "Company") entered into a Termination, Asset Transfer and License Agreement (the "Agreement") with HiFiBiO Inc. ("HiFiBiO"). The Agreement terminates the Exclusive License and Option Agreement between the parties, dated June 16, 2021, as amended on February 14, 2024 (the "License Agreement"), and all rights and obligations of FibroGen under the License Agreement shall cease and terminate, subject to certain survival terms.
Under the Agreement, FibroGen has also licensed HiFiBiO the anti-CCR8 and anti-Gal-9 intellectual property developed by FibroGen. In the event HiFiBiO sublicenses Gal-9 (FG-3165) and/or CCR8 (FG-3175) assets, FibroGen is eligible to receive a mid single-digit to low double-digit share of HiFiBiO's license revenues and low double-digit share of HiFiBiO's commercial royalties. In the case HiFiBiO commercializes either asset, FibroGen has the potential to receive single digit royalties based upon worldwide net sales.
﻿

Contracts

FGEN

FibroGen Terminates License Agreement With HiFiBiO, Transfers Anti-CCR8 And Anti-Gal-9 Assets, And Secures Potential Royalties From Future Sublicensing Or Commercialization

Four Corners Property Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCPT#NYSE">FCPT</a>), a real estate investment trust primarily engaged in the ownership and acquisition of high-quality, net-leased restaurant and retail properties ("FCPT" or the "Company"), is pleased to announce the acquisition of a Tires Plus property for $1.7 million. The property is located in a highly trafficked corridor in Georgia and corporate-operated under a triple net lease with approximately three years of term remaining. The transaction was priced at a 7.4% cap rate on rent as of the closing date and exclusive of transaction costs.
 &nbsp;

FCPT

Four Corners Property Trust Acquires Tires Plus Property For $1.7M

On June 3, 2025, the United States District Court for the District of Connecticut (the "District Court") issued an order granting preliminary approval of the proposed settlement of the consolidated derivative actions captioned In re the Lovesac Company Derivative Action, Case No. 3:24-cv-01260-VAB (D. Conn.), on the terms set out in the Stipulation of Settlement dated May 19, 2025 ("Stipulation of Settlement" and, with its exhibits, the "Settlement Agreement"). On June 6, 2025, the District Court amended the order granting preliminary approval to adjust certain dates in the prior June 3 order.

Legal

LOVE

Federal Court Grants Preliminary Approval Of Lovesac Derivative Lawsuit Settlement On June 3, 2025

Dow Files For Mixed Shelf; Size Not Disclosed

<a href="https://www.bloomberg.com/news/articles/2025-06-13/google-s-plan-to-buy-security-firm-wiz-gets-antitrust-review">https://www.bloomberg.com/news/articles/2025-06-13/google-s-plan-to-buy-security-firm-wiz-gets-antitrust-review</a>

GOOG

GOOGL

'Google's Plan to Buy Security Firm Wiz Gets Antitrust Review'- Bloomberg

Buybacks

FELE

Franklin Electric Completes 1.2M Shares Purchase At $86.78 Each From Patricia Schaefer Settlement Trust

Johnson Controls International Reveals $9B Increase To Share Repurchase Program

OSI Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OSIS#NASDAQ">OSIS</a>) has outperformed the market over the past 20 years by 6.14% on an annualized basis producing an average annual return of 14.43%. Currently, OSI Systems has a market capitalization of $3.86 billion. 
Buying $1000 In OSIS: If an investor had bought $1000 of OSIS stock 20 years ago, it would be worth $14,601.78 today based on a price of $229.54 for OSIS at the time of writing.
<h3>OSI Systems's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749845732_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

OSIS

If You Invested $1000 In This Stock 20 Years Ago, You Would Have This Much Today

Carnival Corporation &amp;&nbsp;plc ((NYSE/LSE: CCL, NYSE:<a href="https://www.benzinga.com/stock/CUK#NYSE">CUK</a>) (the "Company") today announced that it has successfully arranged a new $4.5 billion multi-currency revolving credit facility (the "New Revolver"). &nbsp;The New Revolver matures in June 2030 and will replace the existing multi-currency revolving credit facility of Carnival Holdings (Bermuda) II Limited, a subsidiary of Carnival Corporation. The New Revolver also contains an accordion feature, allowing for up to $1.0 billion of additional revolving commitments.

Carnival Corp & Plc Arranges New $4.5B Multi-Currency Revolving Credit Facility

FDA states heavy workload and limited resources prevent meeting PDUFA goal date of June 17
Agency indicates anticipated decision within four weeks
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.kalvista.com%2F&amp;esheet=54276083&amp;newsitemid=20250613608281&amp;lan=en-US&amp;anchor=KalVista+Pharmaceuticals&amp;index=1&amp;md5=e86059e83cf65cec245451f3ef33b01b">KalVista Pharmaceuticals</a>, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KALV#NASDAQ">KALV</a>) today announced that the U.S. Food and Drug Administration (FDA) has notified the Company that it will not meet the PDUFA goal date for the New Drug Application (NDA) for sebetralstat, the Company's investigational oral on-demand treatment for hereditary angioedema (HAE). The FDA notified the Company on June 13, 2025, that the previously disclosed June 17, 2025 PDUFA goal date will not be met due to heavy workload and limited resources. The FDA indicated that it expects to deliver a decision within approximately four weeks.
The FDA has not requested additional data or studies and has not raised any concerns regarding the safety, efficacy or approvability of sebetralstat. KalVista has addressed all prior information requests in a timely manner, and the Company believes the only remaining item under FDA review is the finalization of the labelling.

KALV

KalVista Pharma Says FDA Will Not Meet PDUFA Goal Date For New Drug Application For Sebetralstat, Oral On-Demand Treatment For Hereditary Angioedema

The S&amp;P Steel Index is gaining in 2025, buoyed by a combination of tariff leverage, robust balance sheets, and strong returns on capital.
Year to date, the S&amp;P Steel Sub-Industry Index is up 8.40% as of June 12, as the US steel sector stabilizes. It has room to grow over the short term after President Trump's decision to double US steel tariff imports from 25% to 50% as of June 4, 2025, following a new executive order.
But tariffs aren&#8217;t the only reason steel stocks are rising.
The trade policy shift, announced in late May during a rally at a U.S. Steel factory near Pittsburgh, immediately sent steel stocks soaring, with Cleveland-Cliffs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLF#NYSE">CLF</a>) rising 26% in a single day following the announcement, while Steel Dynamics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STLD#NASDAQ">STLD</a>) and Nucor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUE#NYSE">NUE</a>) saw gains of 10-11%. "The tariffs effectively raise the price floor for steel in the U.S. market by making imported steel significantly more expensive," said Tracy Shuchart, senior economist at NinjaTrader in New York City. "According to market data, benchmark steel prices have already increased from $725 per metric ton before the tariff announcement to $875 per metric ton currently."
It&#8217;s not only tariffs that are supporting steel industry gains.
"Steel's rally is a mix of short-term catalysts and long-term structural forces," said Dan Buckley, chief analyst at DayTrading.com. "US tariffs are boosting expectations for domestic producers, while sustained federal spending on infrastructure and reshoring is aiding durable demand."
"Add in supply chain restocking, auto sector recovery, and disciplined capital returns from top players like Nucor and Steel Dynamics, and the sector is showing a more stable profile," Buckley added.
The tariff portion of that equation may not have a long shelf life, so investors should proceed cautiously. Talks between the U.S. and Mexico are already underway to curb the 50% tariff figure.
"For example, the two countries are exploring a quota system that would allow a specific amount of Mexican steel to enter the U.S. duty-free or at lower rates, with only excess amounts subject to the full 50% levy," Shuchart noted. "This negotiation explains why some steel stocks like Nucor fell 6.1% on June 11, as investors reacted to the possibility of tariff exemptions. The European Union has also strongly opposed the increased tariffs, warning of potential countermeasures."
<h2 class="wp-block-heading">Benzinga Exclusive: Master Trader Reveals ‘Power Patterns' Behind 100% Gains</h2>
For the last decade, these three "Power Patterns" have delivered winning trades during the summer &#8211; one an astonishing 90% of the time. Now they're firing up again over the next 75 days. Want a 30-year veteran trader to show you how to play them? See <a href="https://events2.benzinga.com/power-pattern-profits-live/?utm_campaign=power-pattern-registration&amp;utm_adType=sponsorad&amp;utm_ad=RD061625&amp;he={{email}}&amp;adt_ei={{email}}&amp;utm_medium=newsletter&amp;el=ResearchDaily">HERE</a> How a Master Trader Plays These "Power Patterns"
Investors should factor in other supportive steel sector impactors also driving industry stocks forward. Shuchart points to infrastructure investment, where ongoing and planned infrastructure projects drive demand for steel products across the United States.
Domestic construction activity is up, too, and in high-growth areas.
"Despite higher interest rates, commercial construction remains relatively robust, supporting demand for structural steel," Shuchart said. "Additionally, key steel-consuming industries like automotive and machinery manufacturing have shown surprising resilience in 2025, and the expansion of renewable energy infrastructure requires significant steel inputs, creating a new demand source for the industry.&#8221;
With a strong tailwind from U.S. government policy and solid fundamentals from the steel sector in place, which steel stocks make the most sense for investors right now? These three steel plays could add a profitable element to your portfolio.
<h2 class="wp-block-heading">Nucor</h2>
Trading at $121 per share and 4.4% over the past month, Charlotte, N.C.-based Nucor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUE#NYSE">NUE</a>), a steel products manufacturer, also offers a sturdy 1.82% dividend yield.
"Despite recent volatility due to potential Mexico tariff negotiations, Nucor remains the premier U.S. steel producer with industry-leading margins, a strong balance sheet, and consistent dividend growth," Shuchar said. "Its EAF production model provides cost flexibility, and its diverse product mix offers exposure to multiple end markets."
<h2 class="wp-block-heading">Steel Dynamics</h2>
At $133 per share and with a 1.50% dividend yield, Steel Dynamics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STLD#NASDAQ">STLD</a>) is up a healthy 16.7% year to date. However, the stock (like Nucor) is down moderately this week after the US-Mexico tariff negotiations went public. Wall Street is buzzing over those talks, which could center on reducing or even removing the 50% tariffs to a lower amount based on historical trade volumes.
Yet there's a lot to like about Steel Dynamics, which, like Nucor, offers investors operational efficiency and one of the lowest production cost structures in the industry. "The company has been expanding its value-added product portfolio, which should support margins even if base steel prices moderate," Shuchar said.
<h2 class="wp-block-heading">ArcelorMittal</h2>
Buckley is bullish on the Luxembourg-based ArcelorMittal (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MT#NYSE">MT</a>), which engages in steelmaking and mining activity. "MT adds global diversification" to the manufacturing section of an investment portfolio," Buckley said. MT shares are up 30.6% year to date at $30 per share with a 1.55% dividend yield.
MT could also benefit from Nippon Steel's purchase of US Steel. Under an agreement inked in October 2024, ArcelorMittal is set up to purchase Nippon's 50% share in a joint venture deal for $1. In addition, MT will deep-six $1 billion of joint venture shareholder loans in an agreement that JP Morgan analyst Dominic O'Kane called a "major positive" for ArcelorMittal.
<h2 class="wp-block-heading">Look for Solid Fundamentals with Steel Stocks</h2>
Don't hit any "buy" buttons on steel stocks until you grasp a company's underlying fundamentals, even if the tariff wars seem to be working out in your favor.
Buckley said investors should prioritize key factors with steel companies. In his view, the best steel investments combine:
<ul class="wp-block-list">
<li>Cost-efficient production.</li>
<li>Strong returns on capital.</li>
<li>Strong balance sheets (i.e., low net debt, high-interest coverage, ample cash reserves, stable working capital, prudent capital expenditure discipline).</li>
<li>Quality net margins (i.e., a ~5% net margin is a solid baseline for this sector, and a 7- 10% range is excellent).</li>
</ul>
"Industry companies with high-margin, value-added products and sustainable dividend growth are best, rather than chasing commodity pricing volatility compared to the overall market," Buckley said. "Overall, steel stocks are less about chasing trends and more about aligning with the economic security playbook we're seeing as a geopolitical theme."
Editorial content from our expert contributors is intended to be information for the general public and not individualized investment advice. Editors/contributors are presenting their individual opinions and strategies, which are neither expressly nor impliedly approved or endorsed by Benzinga.
Photo: Shutterstock

STLD

3 Steel Stocks To Get You Through The Market's Troubles

-- Neil Berkley, M.B.A., appointed Interim Chief Financial Officer, succeeding Marc Grasso, M.D.,&nbsp;effective June 20, 2025 --
SOUTH SAN FRANCISCO, Calif., June 13, 2025 (GLOBE NEWSWIRE) -- Alector, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALEC#NASDAQ">ALEC</a>), a late-stage clinical biotechnology company focused on developing therapies to counteract the devastating progression of neurodegeneration, today announced that its Chief Financial Officer (CFO), Marc Grasso, M.D., will conclude his tenure with the company, effective June 20, 2025, to pursue other opportunities. Neil Berkley, M.B.A., the company's Chief Business Officer, will assume the role of Interim CFO while continuing in his current position.

ALEC

Alector Announces Neil Berkley Appointed Interim Chief Financial Officer, Succeeding Marc Grasso, Effective June 20, 2025

U.S. markets ended a choppy week on a cautious note, as modest gains through Thursday reversed sharply on Friday after escalating tensions between Israel and <a href="https://www.benzinga.com/news/politics/25/06/45922022/trump-issues-stark-warning-to-iran-to-make-a-deal-after-israels-strikes-on-nuclear-sites-just-do-it-before-its-too-late">Iran rattled investor sentiment.</a>
Major equity indices, which had been hovering near all-time highs, pulled back as geopolitical risks surged back to the forefront.
The S&amp;P 500 – as tracked by the Vanguard S&amp;P 500 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VOO#NYSE">VOO</a>) – ended 1.1% lower for the week, falling below the 6,000-point threshold. 
<h3 class="wp-block-heading">Oil's Back In Focus—And Gold Is Eyeing New Highs</h3>
Late Thursday, Israel launched &#8220;Operation Rising Lion,&#8221; a sweeping aerial campaign targeting approximately 100 Iranian nuclear and military installations, reportedly killing several high-ranking officials. Iran responded by launching over 100 drones toward Israeli territory and vowed severe retaliation, raising fears of a <a href="https://www.benzinga.com/news/topics/25/06/45933856/iran-fires-ballistic-missiles-at-israel-tel-aviv-struck">broader regional escalation.</a>
Oil markets reacted swiftly: West Texas Intermediate crude surged past $70 a barrel, capping a double-digit percentage gain for the week — <a href="https://www.benzinga.com/markets/commodities/25/06/45924154/the-120-oil-shock-just-became-a-real-risk-are-we-back-in-2022">its strongest in years.</a>
On the economic front, the much-feared tariff-driven inflation failed to materialize in May, with <a href="https://www.benzinga.com/markets/economic-data/25/06/45881899/inflation-resumes-climb-in-may-but-tariffs-have-yet-to-hit-consumers">consumer</a> and <a href="https://www.benzinga.com/markets/economic-data/25/06/45902987/producer-inflation-rises-less-than-forecasts-in-may-jobless-claims-signal-labor-market-cracks">producer</a> price reports generally coming in broadly below expectations.
Under normal circumstances, such data would have bolstered hopes for Federal Reserve rate cuts and likely sparked a rally on Wall Street. But the rally failed to materialize as soaring energy prices clouded the disinflation narrative.
Sector-wise, energy stocks led the weekly gains, buoyed by the oil rally, while financials underperformed. Oracle Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) <a href="https://www.benzinga.com/analyst-stock-ratings/price-target/25/06/45924707/oracle-to-rally-around-11-here-are-10-top-analyst-forecasts-for-friday">delivered a standout performance</a> – climbing by over 20% on its best weekly return since 2001 – following stronger-than-expected quarterly earnings and upbeat guidance.
Currency markets were also in motion. The U.S. dollar came under renewed pressure, with a key index tracking the greenback falling to its lowest level <a href="https://www.benzinga.com/markets/economic-data/25/06/45906982/dollar-hits-27-month-lows-the-fed-should-cut-next-week-economist-says">in over three years.</a> 
Investors appeared increasingly uneasy about the long-term trajectory of U.S. fiscal policy, particularly as President Donald Trump's sweeping "One Big, Beautiful Bill" heads to the Senate.
Safe-haven demand for precious metals remained robust. Gold extended its powerful 2025 rally, supported by both geopolitical instability and persistent worries over the U.S. debt burden. The precious metal is on track to deliver its strongest <a href="https://www.benzinga.com/markets/guidance/25/06/45928561/gold-biggest-boom-in-decades-and-investors-are-still-missing-out">first-half performance since 1982.</a>
Silver also inched higher, hitting the <a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/06/45847216/silver-supercycle-you-never-have-enough-of-it-hedge-fund-analyst-says-as-50-level-looms">highest levels since 2012</a>.&nbsp;
All eyes now turn to the Federal Reserve's policy meeting next week. While no change to interest rates is expected, markets will scrutinize any shifts in the Fed's economic projections. In March, policymakers forecast 2025 GDP growth at 1.7% — down from 2.1% in December — and a 2.7% average inflation rate, revised upward from 2.5%.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/25/06/45922827/the-dollar-is-crumbling-and-hedge-fund-analyst-says-a-new-global-trade-is-brewing">The Dollar Is Crumbling, And Hedge Fund Analyst Says A New Global Trade Is Brewing </a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Equities

Large Cap

Macro Economic Events

Broad U.S. Equity ETFs

Commodities

Global

Econ #s

Economics

ETFs

ORCL

Soft Inflation Data Meets Middle East Turmoil: This Week In Markets

President Donald Trump is set to host <a href="https://www.benzinga.com/news/politics/25/06/45894541/trump-sports-president-military-birthday-parade">a large military parade </a>in Washington D.C. on Saturday, June 14, an event that coincides with his birthday. It turns out big technology companies could be helping to fund the event alongside taxpayers.
What Happened: Trump's parade to celebrate the 250th anniversary of the U.S. Army on Saturday comes one year before a <a href="https://www.benzinga.com/news/25/05/45512795/gop-megadonor-ken-griffin-donates-15-million-lends-rare-us-constitution-and-bill-of-rights-ahead-of-americas-250th-anniversary">planned semiquincentennial celebration</a> to mark the 250th anniversary of the signing of the Declaration of Independence.
Both events are bringing in a large number of big, well-known companies to make donations to support the efforts, similar to the companies that donated to Trump's inauguration ceremony.
A <a href="https://www.theverge.com/policy/685690/big-tech-trump-military-parade-america250">report </a>from The Verge citing statements from organization planner America250 names Oracle Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>), Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), Coinbase Global Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>), Palantir Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>), Scott's Miracle-Gro Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMG#NYSE">SMG</a>), FedEx Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDX#NYSE">FDX</a>) and Lockheed Martin Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>) as companies that are sponsoring the America250 Foundation.
This congressionally appointed nonprofit is in charge of raising funds for the 250th anniversary next year and also logistics for the parade and festival this weekend.
"Many of these sponsors will support the upcoming grand military parade being held in Washington, D.C. on Saturday, June 14th, to celebrate the U.S. Army's 250th birthday," press <a href="https://america250.org/news/america250-announces-new-sponsors-championing-historic-celebrations-and-events-as-momentum-builds-for-the-countrys-250th-anniversary/">releases </a>from America250 read.
According to The Verge, Meta Platforms Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) was previously named a sponsor by America250 before its logo was removed from the sponsorship page. Meta offered a response to The Verge.
"While we are not currently a sponsor, we have had a historical relationship with America250, and we are actively exploring potential partnership opportunities with them in the future," a Meta spokesperson told The Verge.
Many of the companies chose not to respond to comment to The Verge in the report, but Lockheed Martin confirmed its sponsorship of America250.
Did You Know?
<ul class="wp-block-list">
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent061325">Get Tips On What They Bought And Sold With Our Easy-to-Use Tool</a></li>
</ul>
Why It's Important: The U.S. Army estimates that the cost of the parade this weekend will be between $25 million and $45 million. Army Secretary Dan Driscoll defended the costs to Congress as "a once-in-a-lifetime opportunity to fill up our recruiting pipeline."
The parade is seen as a precursor to next year's celebration and will mainly celebrate the anniversary of the founding of the Army. The parade also takes place on Trump's birthday, which has led many to believe that it will be a celebration of the current president.
Donations to America250 for next year's event are likely being used to help fund this weekend's parade based on the wording in press releases. The question is whether companies that are donating for next year's event are aware that their money is being used for both.
The report of donations from large companies follows a similar path to the large technology and cryptocurrency companies that <a href="https://www.benzinga.com/tech/25/01/42898021/google-donates-1-million-to-trump-inauguration-plans-youtube-livestream-pleased-to-support">helped fund </a>Trump's inauguration. Some of the donations were made by companies that may have been looking to get favors or win political favor with Trump.
Companies helping fund the military parade and birthday celebration could be doing the same.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/politics/25/06/45916986/walmart-heiress-takes-on-trump-with-no-kings-ad-white-house-calls-it-burning-some-of-her-inheritance-for-a-pr-stunt">Walmart Heiress Takes On Trump With &#8216;No Kings&#8217; Ad: White House Calls It &#8216;Burning Some Of Her Inheritance For A PR Stunt&#8217;</a></li>
</ul>
Photo: Shutterstock

Politics

Tech

AMZN

COIN

PLTR

Big Tech Companies Helped Fund Trump's Inauguration, Now They Could Be Funding His Military, Birthday Parade

Vistra (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VST#NYSE">VST</a>) has outperformed the market over the past 5 years by 39.57% on an annualized basis producing an average annual return of 53.32%. Currently, Vistra has a market capitalization of $58.91 billion. 
Buying $100 In VST: If an investor had bought $100 of VST stock 5 years ago, it would be worth $873.69 today based on a price of $173.60 for VST at the time of writing.
<h3>Vistra's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749844908_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning Vistra Stock In The Last 5 Years

In the preceding three months, 21 analysts have released ratings for Deckers Outdoor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DECK#NYSE">DECK</a>), presenting a wide array of perspectives from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">7</td>
<td align="right">5</td>
<td align="right">9</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">5</td>
<td align="right">3</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Deckers Outdoor, revealing an average target of $139.0, a high estimate of $240.00, and a low estimate of $100.00. Experiencing a 23.75% decline, the current average is now lower than the previous average price target of $182.29. 
<img src="https://www.benzinga.com/files/images/story/2025/1749844889_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
The analysis of recent analyst actions sheds light on the perception of Deckers Outdoor by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Christopher Nardone</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$128.00</td>
<td>$154.00</td>
</tr>
<tr>
<td>Jonathan Komp</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$140.00</td>
<td>$160.00</td>
</tr>
<tr>
<td>Ike Boruchow</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$100.00</td>
<td>$120.00</td>
</tr>
<tr>
<td>Jay Sole</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$169.00</td>
<td>$158.00</td>
</tr>
<tr>
<td>Rick Patel</td>
<td>Raymond James</td>
<td>Lowers</td>
<td>Strong Buy</td>
<td>$140.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>Adrienne Yih</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$128.00</td>
<td>$129.00</td>
</tr>
<tr>
<td>Ashley Owens</td>
<td>Keybanc</td>
<td>Maintains</td>
<td>Sector Weight</td>
<td>$150.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>JESALYN Wong</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>In-Line</td>
<td>$110.00</td>
<td>$235.00</td>
</tr>
<tr>
<td>Dana Telsey</td>
<td>Telsey Advisory Group</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$120.00</td>
<td>$240.00</td>
</tr>
<tr>
<td>Tom Nikic</td>
<td>Needham</td>
<td>Lowers</td>
<td>Buy</td>
<td>$120.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>Tom Nikic</td>
<td>Needham</td>
<td>Lowers</td>
<td>Buy</td>
<td>$150.00</td>
<td>$246.00</td>
</tr>
<tr>
<td>John Kernan</td>
<td>TD Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$175.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>Dana Telsey</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$240.00</td>
<td>$240.00</td>
</tr>
<tr>
<td>Ike Boruchow</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$120.00</td>
<td>$115.00</td>
</tr>
<tr>
<td>Adrienne Yih</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$129.00</td>
<td>$231.00</td>
</tr>
<tr>
<td>Jay Sole</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$158.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>Ike Boruchow</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$115.00</td>
<td>$210.00</td>
</tr>
<tr>
<td>Ashley Owens</td>
<td>Keybanc</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$150.00</td>
<td>$230.00</td>
</tr>
<tr>
<td>Paul Lejuez</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$150.00</td>
<td>$215.00</td>
</tr>
<tr>
<td>Anna Andreeva</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$100.00</td>
<td>$210.00</td>
</tr>
<tr>
<td>Jim Duffy</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Hold</td>
<td>$127.00</td>
<td>$185.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Deckers Outdoor. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Deckers Outdoor compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
For valuable insights into Deckers Outdoor's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/DECK/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Deckers Outdoor analyst ratings.</a>
<h2>About Deckers Outdoor</h2>
Founded in 1973, California-based Deckers designs and sells casual and performance footwear, apparel, and accessories. In fiscal 2025, Ugg and Hoka accounted for 51% and 45% of total sales, respectively. The firm also markets niche brands Teva and Ahnu. Deckers produces most of its sales through wholesale partnerships but also operates e-commerce in more than 50 countries and about 180 company-operated stores. It generated 64% of its fiscal 2025 sales in the United States.
<h3>Deckers Outdoor: A Financial Overview</h3>
Market Capitalization: Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.
Revenue Growth: Over the 3M period, Deckers Outdoor showcased positive performance, achieving a revenue growth rate of 6.46% as of 31 March, 2025. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Consumer Discretionary sector.
Net Margin: Deckers Outdoor's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 14.82%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Deckers Outdoor's ROE stands out, surpassing industry averages. With an impressive ROE of 5.89%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Deckers Outdoor's ROA stands out, surpassing industry averages. With an impressive ROA of 4.02%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: With a below-average debt-to-equity ratio of 0.11, Deckers Outdoor adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>The Significance of Analyst Ratings Explained</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

DECK

Analyst Expectations For Deckers Outdoor's Future

In the latest quarter, 23 analysts provided ratings for e.l.f. Beauty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELF#NYSE">ELF</a>), showcasing a mix of bullish and bearish perspectives.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">11</td>
<td align="right">7</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">8</td>
<td align="right">4</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $101.52, a high estimate of $150.00, and a low estimate of $59.00. This current average has increased by 11.29% from the previous average price target of $91.22. 
<img src="https://www.benzinga.com/files/images/story/2025/1749844879_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
A comprehensive examination of how financial experts perceive e.l.f. Beauty is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Anna Glaessgen</td>
<td>B. Riley Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$150.00</td>
<td>$110.00</td>
</tr>
<tr>
<td>Bill Chappell</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$130.00</td>
<td>$125.00</td>
</tr>
<tr>
<td>Joel Beatty</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$145.00</td>
<td>$110.00</td>
</tr>
<tr>
<td>Olivia Tong</td>
<td>Raymond James</td>
<td>Raises</td>
<td>Strong Buy</td>
<td>$130.00</td>
<td>$105.00</td>
</tr>
<tr>
<td>Bill Chappell</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$125.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Andrea Teixeira</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$123.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Olivia Tong</td>
<td>Raymond James</td>
<td>Raises</td>
<td>Strong Buy</td>
<td>$105.00</td>
<td>$95.00</td>
</tr>
<tr>
<td>Korinne Wolfmeyer</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$109.00</td>
<td>$81.00</td>
</tr>
<tr>
<td>Dara Mohsenian</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$105.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Ashley Helgans</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$115.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Susan Anderson</td>
<td>Canaccord Genuity</td>
<td>Raises</td>
<td>Buy</td>
<td>$114.00</td>
<td>$105.00</td>
</tr>
<tr>
<td>Olivia Tong</td>
<td>Raymond James</td>
<td>Raises</td>
<td>Strong Buy</td>
<td>$95.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>Peter Grom</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$84.00</td>
<td>$59.00</td>
</tr>
<tr>
<td>Anna Lizzul</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$95.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Joel Beatty</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$100.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>Korinne Wolfmeyer</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$81.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>Bill Chappell</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$75.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Peter Grom</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$59.00</td>
<td>$74.00</td>
</tr>
<tr>
<td>Olivia Tong</td>
<td>Raymond James</td>
<td>Lowers</td>
<td>Strong Buy</td>
<td>$85.00</td>
<td>$120.00</td>
</tr>
<tr>
<td>Andrea Teixeira</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$70.00</td>
<td>$127.00</td>
</tr>
<tr>
<td>Korinne Wolfmeyer</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$90.00</td>
<td>$102.00</td>
</tr>
<tr>
<td>Linda Bolton Weiser</td>
<td>DA Davidson</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$75.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Linda Bolton Weiser</td>
<td>DA Davidson</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$75.00</td>
<td>$80.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to e.l.f. Beauty. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of e.l.f. Beauty compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of e.l.f. Beauty's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of e.l.f. Beauty's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/ELF/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on e.l.f. Beauty analyst ratings.</a>
<h2>About e.l.f. Beauty</h2>
e.l.f. Beauty Inc is a multi-brand beauty company that offers inclusive, accessible, clean, vegan, and cruelty-free cosmetics and skin care products. The Company's mission is to make beauty accessible to every eye, lip, face, and skin concern. The company offers cosmetic accessories for women, which include eyeliner, mascara, false eyelashes, lipstick, foundation for the face, moisturizer, cleanser, and other tools through its stores and e-commerce channels.
<h3>e.l.f. Beauty: A Financial Overview</h3>
Market Capitalization Analysis: The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.
Revenue Growth: e.l.f. Beauty's remarkable performance in 3M is evident. As of 31 March, 2025, the company achieved an impressive revenue growth rate of 3.58%. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Consumer Staples sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 8.49%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): e.l.f. Beauty's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 3.7% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): e.l.f. Beauty's ROA excels beyond industry benchmarks, reaching 2.25%. This signifies efficient management of assets and strong financial health.
Debt Management: e.l.f. Beauty's debt-to-equity ratio is below the industry average. With a ratio of 0.41, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Breaking Down e.l.f. Beauty: 23 Analysts Share Their Views

Press Releases

Catheter Precision, Inc. Announces New Chief Financial Officer

Catheter Precision, Inc.  Announces Initial LockeT Purchase From the University of Tennessee Medical Center

Catheter Precision, Inc.  Announces Definitive Agreement to Acquire PeriKard, LLC

Catheter Precision to Attend the 30th International Atrial Fibrillation Symposium

Catheter Precision, Inc.  Announces The Closing of its Acquisition of PeriKard, LLC

Catheter Precision Inc. Engages PCG Advisory to Broaden Investor Relations Strategy

Catheter Precision, Inc.  Announces Fourth Quarter and Full Year 2024 Update and Financial Results

Earnings

Catheter Precision, Inc. Announces First Quarter 2025 Update and Financial Results

Comments

Catheter Precision

Actualités

Dernières nouvelles pour Catheter Precision (AMEX:VTAK) Stock

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL